Position in PHAT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$851,922
-$1,102,061 QoQ
Shares Held
76,681
-34.9% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. PHAT ranks #265 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $851,922 | 76,681 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,953,983 | 117,781 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,008,092 | 255,573 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,485,757 | 154,928 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $7,091,567 | 1,131,032 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,847,165 | 966,400 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,945,976 | 439,490 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $7,854,746 | 762,597 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,518,635 | 237,160 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,137,147 | 124,551 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $811,387 | 78,244 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,036,507 | 72,382 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $669,001 | 93,698 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $776,286 | 69,188 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,024,121 | 92,430 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $918,791 | 108,862 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,151,403 | 84,600 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,737,431 | 139,168 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $858,127 | 26,733 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $896,751 | 26,492 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,216 | 59 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $263,534 | 7,933 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $40,153 | 1,095 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $109,656 | 3,332 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $21,482 | 832 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||